skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Information Types

Show More


Show More

Show More

Product Listing

4 product(s) and free and sample content

From: Datamonitor Healthcare

Datamonitor Healthcare

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 26 Oct 2016

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 20 Oct 2016

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deal trends

From: Biomedtracker

Biomedtracker: follow the drug development process

Track and assess key events that will impact a drug’s probability of technical success and approval.

  • Stay up to date
  • Get ahead of the competition
  • Conference coverage


Report Extract: Q3 2017 Outlook Report

17 Jul 2017

In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Alzheimers Cancer Drug approval


Finding Finance: Pharma, Biotech & Medtech Capital Raising 2016

23 Mar 2017

There is no doubt that 2016 will be marked as year of surprising results. None more so than how life science companies fared in the capital markets.

Topic Business strategies

From: Scrip


Timely news and in-depth insight. Essential for anyone making commercial decisions in the pharmaceutical industry.

  • Follow market developments
  • Go beyond the news
  • Hear from news makers

Strategic Transactions, Scrip

Building something great: UK's Global Bioscience Cluster 2016

22 May 2017

Featured recently in The Telegraph and The Times, Building something great: UK’s Global Bioscience Cluster 2016, the pivotal report from Informa Pharma Intelligence and The UK BioIndustry Association, is now available to you in its entirety as a free download.


As Digital Channels Grow In Importance, AZ, Lilly, GSK Seen As Key Engagers

By Anju Ghangurde 18 Jul 2017

Digital physician engagement channels appear to be closing in on the traditional face-to-face approach.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: